Skip to main navigation Skip to search Skip to main content

A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations

Walter Fiedler*, Sabine Kayser, Maxim Kebenko, Melanie Janning, Jürgen Krauter, Marcus Schittenhelm, Katharina Götze, Daniela Weber, Gudrun Göhring, Veronica Teleanu, Felicitas Thol, Michael Heuser, Konstanze Döhner, Arnold Ganser, Hartmut Döhner, Richard F. Schlenk

*Corresponding author for this work
104   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science